☆ 4.5 Article

Interpreting vaccine efficacy trial results for infection and transmission

VACCINE (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Multidisciplinary Sciences

Model-informed COVID-19 vaccine prioritization strategies by age and serostatus

Kate M. Bubar et al.

Summary: The study found that prioritizing the vaccine for adults aged 20 to 49 can minimize the number of cases, while prioritizing the vaccine for adults over 60 can minimize mortality and years of life lost. Redirecting vaccine doses to seronegative individuals through individual-level serological tests can improve the impact of each dose.

SCIENCE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening

Daniel B. Larremore et al.

Summary: The COVID-19 pandemic has led to a public health crisis due to the spread of SARS-CoV-2 through presymptomatic, symptomatic, and asymptomatic individuals. Effective population screening for the virus is essential for reopening societies and controlling its spread, with testing frequency and reporting speed playing crucial roles in its success. Test sensitivity is only marginally important compared to these factors.

SCIENCE ADVANCES (2021)

添加到收藏夹

Article Medicine, General & Internal

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey et al.

Summary: The AZD1222 vaccine has been approved for emergency use in the UK with an interval of 4-12 weeks between doses. Analysis shows that the vaccine is efficacious with two doses and provides immunoprotection after the first dose before the second dose is administered.

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov et al.

Summary: The Gam-COVID-Vac vaccine showed 91.6% efficacy against COVID-19 in the phase 3 trial, with good safety and tolerability in a large cohort of participants.

LANCET (2021)

添加到收藏夹

Letter Medicine, General & Internal

Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients

Sharon Amit et al.

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight US Locations, December 2020-March 2021

Mark G. Thompson et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Review Infectious Diseases

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis

Muge Cevik et al.

Summary: This study aimed to characterize the viral load dynamics, duration of viral shedding, and viable virus shedding of SARS-CoV-2 in various body fluids. The findings suggest that while SARS-CoV-2 RNA shedding can be prolonged in respiratory and stool samples, the duration of viable virus shedding is relatively short-lived.

LANCET MICROBE (2021)

添加到收藏夹

Article Biology

SARS-CoV-2 (COVID-19) by the numbers

Yinon M. Bar-On et al.

ELIFE (2020)

添加到收藏夹

Editorial Material Multidisciplinary Sciences

VIEWPOINT: COVID-19 Understanding COVID-19 vaccine efficacy

Marc Lipsitch et al.

SCIENCE (2020)

添加到收藏夹

Review Medicine, General & Internal

Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research

Conor McAloon et al.

BMJ OPEN (2020)

添加到收藏夹

Article Biology

Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset

Benny Borremans et al.

ELIFE (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Analyzing Vaccine Trials in Epidemics With Mild and Asymptomatic Infection

Rebecca Kahn et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2019)

添加到收藏夹

Article Public, Environmental & Occupational Health

Measurement of Vaccine Direct Effects Under the Test-Negative Design

Joseph A. Lewnard et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2018)

添加到收藏夹

Article Health Care Sciences & Services

Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses

Miguel A. Hernan et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)

添加到收藏夹

Editorial Material Immunology

Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials

Justin J. O'Hagan et al.

AIDS (2012)

添加到收藏夹

Editorial Material Public, Environmental & Occupational Health

The Hazards of Hazard Ratios

Miguel A. Hernan

EPIDEMIOLOGY (2010)

添加到收藏夹

Article Immunology

Estimation of vaccine efficacy against acquisition of pneumococcal carriage

Hanna Rinta-Kokko et al.

VACCINE (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.